Stephen Willey
Stock Analyst at Stifel
(3.04)
# 1,311
Out of 4,876 analysts
131
Total ratings
39.78%
Success rate
1.82%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CBIO Crescent Biopharma | Initiates: Buy | $28 | $17.18 | +62.95% | 1 | Jun 25, 2025 | |
| INCY Incyte | Upgrades: Buy | $75 → $107 | $70.06 | +52.73% | 6 | Jun 16, 2025 | |
| MGNX MacroGenics | Maintains: Hold | $6 → $5 | $1.25 | +300.00% | 3 | May 14, 2025 | |
| EXEL Exelixis | Maintains: Hold | $36 → $38 | $43.60 | -12.84% | 18 | May 14, 2025 | |
| BOLT Bolt Biotherapeutics | Maintains: Hold | $25 → $20 | $5.61 | +256.51% | 4 | May 13, 2025 | |
| NRIX Nurix Therapeutics | Maintains: Buy | $36 → $35 | $11.74 | +198.13% | 5 | Apr 9, 2025 | |
| NKTX Nkarta | Maintains: Buy | $15 → $14 | $1.73 | +709.25% | 3 | Mar 27, 2025 | |
| VOR Vor Biopharma | Maintains: Buy | $12 → $5 | $1.07 | +367.29% | 5 | Mar 21, 2025 | |
| ABCL AbCellera Biologics | Maintains: Buy | $12 → $10 | $3.65 | +173.97% | 5 | Feb 28, 2025 | |
| GERN Geron | Maintains: Buy | $8 → $4 | $1.51 | +165.78% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $97 → $96 | $101.45 | -5.37% | 6 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $27 → $2.5 | $1.21 | +106.61% | 7 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $120 | $2.01 | +5,870.15% | 2 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $28 | $12.28 | +128.01% | 6 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $8.90 | +428.39% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $0.78 | +412.82% | 7 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $34 → $3 | $1.94 | +54.64% | 3 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 | $2.70 | +159.26% | 10 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $1.65 | +143.16% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $62 | $32.26 | +92.22% | 5 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $2.66 | +238.98% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.70 | +605.88% | 1 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $228 → $288 | $2.23 | +12,814.80% | 4 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $21 | $3.00 | +600.00% | 2 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 → $4 | $0.88 | +352.08% | 7 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $123 | $319.11 | -61.46% | 3 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $48 → $47 | $39.73 | +18.30% | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $102 → $109 | $54.56 | +99.78% | 3 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Terminates: Hold | n/a | $19.88 | - | 2 | Jun 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $23 | $6.41 | +259.09% | 5 | Feb 7, 2018 |
Crescent Biopharma
Jun 25, 2025
Initiates: Buy
Price Target: $28
Current: $17.18
Upside: +62.95%
Incyte
Jun 16, 2025
Upgrades: Buy
Price Target: $75 → $107
Current: $70.06
Upside: +52.73%
MacroGenics
May 14, 2025
Maintains: Hold
Price Target: $6 → $5
Current: $1.25
Upside: +300.00%
Exelixis
May 14, 2025
Maintains: Hold
Price Target: $36 → $38
Current: $43.60
Upside: -12.84%
Bolt Biotherapeutics
May 13, 2025
Maintains: Hold
Price Target: $25 → $20
Current: $5.61
Upside: +256.51%
Nurix Therapeutics
Apr 9, 2025
Maintains: Buy
Price Target: $36 → $35
Current: $11.74
Upside: +198.13%
Nkarta
Mar 27, 2025
Maintains: Buy
Price Target: $15 → $14
Current: $1.73
Upside: +709.25%
Vor Biopharma
Mar 21, 2025
Maintains: Buy
Price Target: $12 → $5
Current: $1.07
Upside: +367.29%
AbCellera Biologics
Feb 28, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $3.65
Upside: +173.97%
Geron
Feb 27, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.51
Upside: +165.78%
Feb 21, 2025
Maintains: Buy
Price Target: $97 → $96
Current: $101.45
Upside: -5.37%
Jan 10, 2025
Downgrades: Hold
Price Target: $27 → $2.5
Current: $1.21
Upside: +106.61%
Nov 14, 2024
Maintains: Buy
Price Target: $150 → $120
Current: $2.01
Upside: +5,870.15%
Oct 28, 2024
Maintains: Buy
Price Target: $21 → $28
Current: $12.28
Upside: +128.01%
Oct 8, 2024
Initiates: Buy
Price Target: $47
Current: $8.90
Upside: +428.39%
Aug 20, 2024
Maintains: Buy
Price Target: $8 → $4
Current: $0.78
Upside: +412.82%
Jul 9, 2024
Downgrades: Hold
Price Target: $34 → $3
Current: $1.94
Upside: +54.64%
Apr 12, 2024
Maintains: Hold
Price Target: $7
Current: $2.70
Upside: +159.26%
Dec 19, 2023
Maintains: Buy
Price Target: $3 → $4
Current: $1.65
Upside: +143.16%
Dec 18, 2023
Maintains: Buy
Price Target: $53 → $62
Current: $32.26
Upside: +92.22%
Jan 27, 2023
Initiates: Buy
Price Target: $9
Current: $2.66
Upside: +238.98%
Nov 28, 2022
Initiates: Buy
Price Target: $12
Current: $1.70
Upside: +605.88%
Jun 26, 2020
Downgrades: Hold
Price Target: $228 → $288
Current: $2.23
Upside: +12,814.80%
Mar 17, 2020
Maintains: Buy
Price Target: $22 → $21
Current: $3.00
Upside: +600.00%
Jul 29, 2019
Downgrades: Hold
Price Target: $10 → $4
Current: $0.88
Upside: +352.08%
Aug 13, 2018
Maintains: Buy
Price Target: $125 → $123
Current: $319.11
Upside: -61.46%
Aug 8, 2018
Maintains: Hold
Price Target: $48 → $47
Current: $39.73
Upside: +18.30%
Aug 3, 2018
Maintains: Buy
Price Target: $102 → $109
Current: $54.56
Upside: +99.78%
Jun 25, 2018
Terminates: Hold
Price Target: n/a
Current: $19.88
Upside: -
Feb 7, 2018
Maintains: Buy
Price Target: $20 → $23
Current: $6.41
Upside: +259.09%